Google+ Facebook Twitter Twitter

Newly discovered genetic defect

In the quest to find the origin of the puzzling symptoms in four children, researchers from St. Anna Children’s Cancer Research Institute (CCRI) and the Medical University of Vienna have discovered a completely new disease, linking disruptions of blood formation, the immune system and inflammation.

The discovery provides the basis for a better understanding of similar diseases.

A newly identified defect in the DOCK11 gene leads to abnormalities in both white and red blood cells, they reported.

“Such rare and previously unknown diseases provide valuable insights into the fundamental principles of blood formation and the immune system. They allow us to better understand the dysregulated processes underlying these diseases,” said Kaan Boztug, senior author.

The gene defect was first identified in a young patient from Spain, where despite repeated tests, no explanation could be found for the severe inflammation affecting various organs such as the kidneys, intestines, and skin.

Image credit | St.-Anna-Children’s-Cancer-Research-Institute

Related Articles

Oxford Autoimmune Neurology Diagnostic Laboratory -CREDIT-Supplied

My lab: antibodymediated autoimmune neurology

A guided tour of the Oxford Autoimmune Neurology Diagnostic Laboratory.

blood sample-CREDIT-shutterstock-631151198

Vaccine for highly fatal tropical disease

In a mouse study, UCLA researchers tested a vaccine against the bacterium that causes melioidosis and found it was highly protective against the disease.

neutrophil cell trapping bacteria Image Credit | Science Photo Library-p2760184

Cancer and stress breakthrough

Stress hormones can trigger the formation of structures that make body tissues more susceptible to metastasis, research has found.

Tuberculosis vaccine bacteria-Image Credit | Science Photo Library - b2201433

“TB vaccine shrinks mice cancer tumours”

A new study found that a single dose of Bacillus Calmette-Guérin (BCG), the vaccine for tuberculosis (TB), reduced liver tumour burden and extended the survival of mice with liver cancer.